Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001140361-25-039330
Filing Date
2025-10-24
Accepted
2025-10-24 21:00:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4048
  Complete submission text file 0001140361-25-039330.txt   5600
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Subject) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36728 | Film No.: 251417293
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 65 COMMERCE WAY HACKENSACK NJ 07601
Business Address
Grossman Adam S (Reporting) CIK: 0001542517 (see all company filings)

Type: 144